UPDATE : Friday, January 17, 2020
Deaths by suicides, infections surged in 2018: data
The number of deaths by incidents increased in 2018 for the first time in f...
by Song Soo-youn  |  2019-12-10 14:17
Samsung Bioepis to start P3 trial for Ontruzant in China
Samsung Bioepis said that China’s National Medical Products Administration ...
by Lee Han-soo  |  2019-12-10 14:16
Sanofi, Hanmi to look for new partner to commercialize efpeglenatide
Hanmi Pharmaceutical and Sanofi are looking for a new partner to commercial...
by Lee Han-soo  |  2019-12-10 11:43
Samyang Biopharma USA, Talix Therapeutics to co-develop immunotherapy candidates
Samyang Biopharm USA said Tuesday it has signed a deal to develop a new imm...
by Lee Han-soo  |  2019-12-10 11:43
Samsung execs get jail term for destroying evidence
A Seoul court gave jail terms to Samsung executives for destroying evidence...
by Jeong Sae-im  |  2019-12-10 11:43
Korea selected as 'Medical Tourism Destination of the Year'
Korea received the "Medical Tourism Destination of the Year" award during t...
by Lee Han-soo  |  2019-12-09 17:43
AbbVie's releases new data for chronic lymphocytic leukemia treatment
AbbVie has presented new long-term data, further supporting the sustained c...
by Lee Han-soo  |  2019-12-09 17:42
Japan OKs Medipost's P2 trial of stem cell-serviced osteoarthritis treatment
Medipost said Japan's Ministry of Health, Labour and Welfare has approv...
by Lee Han-soo  |  2019-12-09 16:15
Genematrix wins CE certification for respiratory disease virus detection kit
Genematrix said that it has received the Conformite Europeenne (CE) Mark fo...
by Lee Han-soo  |  2019-12-09 15:36
Will partial success of Biogen’s Alzheimer’s drug lead to FDA approval?
As preannounced by Biogen in October, its Alzheimer's drug candidate ad...
by Kim Yun-mi  |  2019-12-09 14:39
New MSD labor union launched with fresh resolve
A new MSD Korea labor union has kicked off. The new union consists of emplo...
by Jeong Sae-im  |  2019-12-09 14:37
Celltrion unveils long-term P3 trial results for Truxima in US
Celltrion said that it has presented the long-term follow-up results of its...
by Lee Han-soo  |  2019-12-09 10:36
AMC unravels clues in treating relapsing, metastatic bladder cancer
Asan Medical Center researchers have clarified the pathogenesis of cancer s...
by Lee Han-soo  |  2019-12-06 18:22
Gemvax & Kael unveils P2 trial result for Alzheimer treatment
Gemvax & Kael said that it presented the results of phase 2 clinical trial ...
by Lee Han-soo  |  2019-12-06 17:06
AbbVie’s Venclexta nears insurance benefit
AbbVie Korea’s Venclexta Tab. (ingredient: venetoclax), a drug for recurren...
by Kim Eun-young  |  2019-12-06 16:35
Syntekabio, CHA Hospital to co-develop immunotherapy
Syntekabio said that it will develop immunotherapy agents jointly with CHA ...
by Lee Han-soo  |  2019-12-06 16:32
Medpacto vows to become global company specializing in biomarker-based drugs
Medpacto, a subsidiary of Theregen ETEX, plans to develop Vactosertib, an i...
by Lee Han-soo  |  2019-12-06 15:03
Petitioner demands broader benefit for ovarian cancer drug Zejula
The government granted insurance benefit to Takeda's ovarian cancer tre...
by Song Soo-youn  |  2019-12-06 15:02
China OKs Humedix's hyaluronic acid filler
Humedix said that China's National Medical Products Administration (NMP...
by Lee Han-soo  |  2019-12-06 15:02
Foreign trainee doctors to get easier extension of training
Foreign doctors receiving training at local medical institutions will find ...
by Kwak Sung-sun  |  2019-12-06 12:42
Back to Top